De Novo Cytokine Mimics Have Improved Therapeutic Properties

2019 Cancer Discovery  
A de novo IL2/IL15 mimic has improved antitumor activity and reduced toxicity compared with native IL2.
doi:10.1158/2159-8290.cd-rw2019-008 pmid:34468366 fatcat:q2qvldx4mjd5bndqnarjzbeksa